本页面由Tiger Trade Technology Pte. Ltd.提供服务

CG Oncology Inc.

62.40
-0.7300-1.16%
盘后:62.30-0.1000-0.16%19:30 EDT
成交量:118.86万
成交额:7,444.78万
市值:55.31亿
市盈率:-22.91
高:63.85
开:61.92
低:61.52
收:63.13
52周最高:80.97
52周最低:35.80
股本:8,864.04万
流通股本:7,771.02万
量比:1.71
换手率:1.53%
股息:- -
股息率:- -
每股收益(TTM):-2.7235
每股收益(LYR):-2.0826
净资产收益率:-26.41%
总资产收益率:-17.67%
市净率:5.37
市盈率(LYR):-29.96

数据加载中...

2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report